Insider · CIK 0001839046

Gault Cheryl

Reports to the SEC for 2 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001839046

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-30	RAPPRapport Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−7,925 sh	$33.04	−$262K	141,989
2026-09-30	RAPPRapport Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−2,075 sh	$33.76	−$70K	139,914
2026-06-30	RAPPRapport Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−1,900 sh	$40.09	−$76.2K	158,014
2026-06-30	RAPPRapport Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−3,792 sh	$41.39	−$157K	154,222
2026-06-30	RAPPRapport Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−3,308 sh	$42.17	−$140K	150,914
2026-06-30	RAPPRapport Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−1,000 sh	$43.15	−$43.2K	149,914
2026-03-30	RAPPRapport Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−7,161 sh	$28.04	−$201K	162,753
2026-03-30	RAPPRapport Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−2,839 sh	$28.55	−$81.1K	159,914
2026-03-05	RAPPRapport Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−2,014 sh	$28.93	−$58.3K	169,914
2026-02-02	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+132K sh	—	—	132,000
2025-11-26	RAPPRapport Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+5,000 sh	$1.80	+$9,000	176,928
2025-11-26	RAPPRapport Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−5,000 sh	$30.10	−$150K	171,928
2025-11-26	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,000 sh	—	—	105,407
2025-09-08	RAPPRapport Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+5,000 sh	$1.80	+$9,000	176,928
2025-09-08	RAPPRapport Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−5,000 sh	$38.33	−$192K	171,928
2025-09-08	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,000 sh	—	—	110,407
2025-03-03	RAPPRapport Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+14K sh	—	—	171,928
2025-02-03	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+129K sh	—	—	129,000
2024-06-06	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+88.4K sh	—	—	88,442
2022-01-20	KRSAKorsana Biosciences, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+135K sh	—	—	135,000
2021-12-09	KRSAKorsana Biosciences, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+100K sh	—	—	100,000

Recent filings

Accepted (ET)
Oct 14
Gault Cheryl0001193125-26-410734
SEC(opens sec.gov)
Jul 14
Gault Cheryl0001193125-26-292546
SEC(opens sec.gov)
Mar 314
Gault Cheryl0001193125-26-134684
SEC(opens sec.gov)
Mar 94
Gault Cheryl0001193125-26-098488
SEC(opens sec.gov)
Feb 44
Gault Cheryl0001193125-26-037529
SEC(opens sec.gov)
Dec 14
Gault Cheryl0001193125-25-303910
SEC(opens sec.gov)
Sep 104
Gault Cheryl0001839046-25-000004
SEC(opens sec.gov)
Mar 54
Gault Cheryl0000950170-25-033797
SEC(opens sec.gov)
Feb 44
Gault Cheryl0000950170-25-013750
SEC(opens sec.gov)
Jun 104
Gault Cheryl0000950170-24-071540
SEC(opens sec.gov)
Jan 244
Gault Cheryl0001140361-22-002451
SEC(opens sec.gov)

Companies

Address

RAPPORT THERAPEUTICS, INC. 99 HIGH STREET, SUITE 2100

BOSTON, MA, 02110